The 4d bioprinting global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
4D Bioprinting Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The 4D bioprinting market size has grown exponentially in recent years. It will grow from $.07 billion in 2023 to $0.09 billion in 2024 at a compound annual growth rate (CAGR) of 30.3%. The growth in the historic period can be attributed to rise in geriatric population, increasing healthcare expenditure, rise in 3D bioprinting startups, increasing investments in R&D, growing prevalence of chronic diseases.
The 4D bioprinting market size is expected to see exponential growth in the next few years. It will grow to $0.26 billion in 2028 at a compound annual growth rate (CAGR) of 29.9%. The growth in the forecast period can be attributed to increasing demand for organ transplant, rising aging population, increasing prevalence of chronic diseases, increasing healthcare expenditure, rising demand for personalized medicine. Major trends in the forecast period include technological advancements, collaborations between academia and industry, integration of artificial intelligence, shift towards decentralized manufacturing, integration with 3D imaging technologies.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/4d-bioprinting-global-market-report
Scope Of 4D Bioprinting Market
The Business Research Company’s reports encompass a wide range of information, including:
- Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
- Drivers: Examination of the key factors propelling market growth.
- Trends: Identification of emerging trends and patterns shaping the market landscape.
- Key Segments: Breakdown of the market into its primary segments and their respective performance.
- Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
- Macro Economic Factors: Assessment of broader economic elements impacting the market.
4D Bioprinting Market Overview
Market Drivers –
The increasing demand for organ transplants is expected to propel the growth of the 4D bioprinting market going forward. Organ transplants involve surgically removing an organ or tissue from one person (the donor) and placing it in another person (the recipient) who needs that organ due to organ failure or dysfunction. The demand for organ transplants arises from the critical need to save lives and improve the quality of life for individuals suffering from organ failure or dysfunction. Organ transplants use 4D bioprinting to advance regenerative medicine by precisely fabricating complex tissues and organs with functional capabilities, offering hope for addressing the shortage of donor organs and improving transplant outcomes. For instance, in January 2022, according to the Organ Procurement and Transplantation Network (OPTN), a US-based government organization, in 2021, the number of organ transplantations conducted in the United States reached 41,354, marking a 5.90% rise from the prior year. Therefore, the increasing demand for organ transplants is driving the growth of the 4D bioprinting market.
4D Bioprinting’s Role In Driving The Growth Of Personalized Medicine
The rising demand for personalized medicine is expected to fuel the growth of the 4D bioprinting market going forward. Personalized medicine refers to a medical approach that tailors healthcare decisions, practices, interventions, and treatments to individual characteristics of each patient. 4D bioprinting plays a crucial role in personalized medicine by enabling the fabrication of smart, environmentally responsive biological structures, tissues, and organs that can adapt to various environmental changes. For instance, in 2022, according to Personalized Medicine Coalition, a US-based professional membership organization, the approval of 12 new personalized medicines accounted for about 34% of all newly approved therapies, marking a significant uptick from prior years. Therefore, the rising demand for personalized medicine is driving the growth of the 4D bioprinting market.
Market Trends –
Major companies operating in the 4D bioprinting market are developing strategic partnerships to facilitate the printing of micro-scale geometries. Collaborating with other companies or organizations can provide access to specialized equipment, facilities, and resources that may be costly or challenging to acquire independently, enabling more comprehensive research and development activities. For instance, in December 2021, 4D Biomaterials, a UK-based chemical manufacturing company, partnered with Boston Micro Fabrication, a US-based micro precision 3D printing company. The partnership between 4D Biomaterials and Boston Micro Fabrication (BMF) aims to revolutionize the manufacturing of implantable medical devices by enabling micro 3D printing applications using 4Degra bioresorbable materials. This collaboration combines BMF’s microscale 3D printing systems with 4D Biomaterials’ 4Degra resin inks, allowing the printing of micro-scale geometries for various medical device applications, from rigid orthopedic devices to soft tissue applications.
The 4D bioprinting market covered in this report is segmented –
1) By Type Of Technology: Extrusion-Based Technology, Laser-Based Technology, Inkjet-Based Technology, Other Types
2) By Application Area: Biomedical Application, Other Applications
3) By End-User: Pharmaceutical And Biotechnology Companies, Academic Research And Development, Other End-Users
Get an inside scoop of the 4d bioprinting market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=14235&type=smp
Regional Insights –
North America was the largest region in the 4D bioprinting market in 2023. The regions covered in the 4D bioprinting market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the 4D bioprinting market are 3D Systems Corporation, CELLINK AB, EnvisionTEC Inc., Advanced Solutions Life Sciences, Nanoscribe, Aspect Biosystems Ltd., Aleph Farms, BioBots Inc., Sculpteo, Prellis Biologics, Rokit Healthcare, Cyfuse Biomedical, 3D Bioprinting Solutions, 4D Biomaterials Ltd., Allevi Inc., Cellenion, FluidForm, Methuselah Health, Nanofabrica, OxSyBio Ltd., Poietis S.A.S., REGEMAT 3D S.L., Replicel Life Sciences Inc., VIVAX BIO, Organovo Holdings Inc.
Table of Contents
1. Executive Summary
2. 4D Bioprinting Market Report Structure
3. 4D Bioprinting Market Trends And Strategies
4. 4D Bioprinting Market – Macro Economic Scenario
5. 4D Bioprinting Market Size And Growth
…..
27. 4D Bioprinting Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
